Floatz logo

Flublok Quadrivalent

Pneumonia

Kaiser PermanentevaccineDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Pneumonia cohort.

Asset / SponsorPhaseRating
Linezolid
University Ghent
Phase 4BB
Ap-Pa02
Armata Pharmaceuticals, Inc.
Phase 2BB
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
Denver Health and Hospital Authority
Phase 4BB
Amikacin
Asian Institute of Gastroenterology, India
Phase 4BB
NORMAL HUMAN SERUM ALBUMIN
EASL - CLIF Consortium
Phase 4BB

View all 26 →

Same molecule, other indications

Flublok Quadrivalent is also rated in:

influenzaDormant
D
Indicative ·
30 / 100
View asset →
respiratory tract infectious disorderDormant
D
Indicative ·
30 / 100
View asset →
acute myocardial infarctionDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →